Calcium-dependent HLA-DQ epitope revealed by EDTA mediated inhibition of antibody reactions in the Luminex single antigen bead assay.
Autor: | de Marco R; Immunogenetics Institute-IGEN, Associação Fundo de Incentivo à Pesquisa (AFIP), São Paulo, Brazil., Noronha IH; Immunogenetics Institute-IGEN, Associação Fundo de Incentivo à Pesquisa (AFIP), São Paulo, Brazil., Bottino LZMF; Immunogenetics Institute-IGEN, Associação Fundo de Incentivo à Pesquisa (AFIP), São Paulo, Brazil., Dos Silva AAS; Immunogenetics Institute-IGEN, Associação Fundo de Incentivo à Pesquisa (AFIP), São Paulo, Brazil., Liwski R; Department of Pathology and Laboratory Medicine, Dalhousie University, Halifax, Canada., Gerbase-DeLima M; Immunogenetics Institute-IGEN, Associação Fundo de Incentivo à Pesquisa (AFIP), São Paulo, Brazil. |
---|---|
Jazyk: | angličtina |
Zdroj: | HLA [HLA] 2024 Aug; Vol. 104 (2), pp. e15628. |
DOI: | 10.1111/tan.15628 |
Abstrakt: | Complement mediated interference with the detection of antibodies targeting HLA is a known limitation of the single antigen bead (SAB) Luminex assay. Ethylenediaminetetraacetic acid (EDTA) is currently the serum treatment of choice in most histocompatibility laboratories to block complement activation by chelating calcium. The purpose of this study was to investigate a serum with an antibody reactivity to HLA-DQ6, 7, 8 and 9 molecules, in the Luminex SAB assay, that was inhibited by treatment with EDTA. Serum was from a 55-year-old highly sensitised female renal transplant candidate that contained, among others, antibodies to an epitope containing the 74EL eplet, shared by HLA-DQ6, DQ7, DQ8 and DQ9 molecules. Serum samples were treated with EDTA, dithiothreitol (DTT), or heat prior to testing by SAB assay. EDTA-treated serum was also tested after the addition of calcium chloride (CaCl (© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.) |
Databáze: | MEDLINE |
Externí odkaz: |